Development
| Drugs |
INN |
Discovery |
Preclinical |
Phase I |
Phase II |
Phase III |
Reg&Comm |
| Novel drugs |
| AURIXIM |
Rituximab conjugate |
|
|
|
|
|
|
| BI-CON-02 |
Trastuzumab conjugate |
|
|
|
|
|
|
| Generic |
| NESCLER |
Fingolimod |
|
|
Bioequivalence studies |
|
| Biosimilars |
| RITUMAX |
Rituximab |
|
|
|
|
|
|
| BI-MAB-03 |
Trastuzumab |
|
|
|
|
|
|
| BI-MAB-02 |
Bevacizumab |
|
|
|
|
|
|
